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Philippines; 3School of Computer and Information Technology, Nanyang Normal University, Nanyang 473000, ChinaN6-methyladenosine (m6A) is one of the most common and
abundant modifications in RNA, which is related to many bio-
logical processes in humans. Abnormal RNAmodifications are
often associated with a series of diseases, including tumors,
neurogenic diseases, and embryonic retardation. Therefore,
identifying m6A sites is of paramount importance in the
post-genomic age. Although many lab-based methods have
been proposed to annotate m6A sites, they are time consuming
and cost ineffective. In view of the drawbacks of the intrinsic
methods in RNA sequence recognition, computational
methods are suggested as a supplement to identify m6A sites.
In this study, we develop a novel feature extraction algorithm
based on the frequent gapped k-mer pattern (FGKP) and apply
the linear regression to construct the prediction model. The
new predictor is used to identify m6A sites in the Saccharo-
myces cerevisiae database. It has been shown by the 10-fold
cross-validation that the performance is better than that of
recent methods. Comparative results indicate that our model
has great potential to become a useful and effective tool for
genome analysis and gain more insights for locating m6A sites.Received 9 May 2019; accepted 3 October 2019;
https://doi.org/10.1016/j.omtn.2019.10.001.
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Over 100 modifications occur in RNA.1 The functions of internal
modifications of mRNA are used to keep the stability of mRNA,
and the most common internal modifications of mRNA include
N6-methyladenosine (m6A), N1-methyladenosine (m1A), 5-methyl-
cytosine (m5C). Among them, global scientists have verifiedmany en-
zymes that m6A engages, such as histone demethylases, methylase,
and methylation recognition enzyme.2 Abnormal m6A modifications
are often related to a series of diseases, including tumors, neurogenic
diseases, and embryonic retardation.3 RNAm6A was first observed in
1970s.4 Since then, m6A is found in a wide spectrum of all living or-
ganisms and linked to many important roles of biological activities,
including mRNA splicing, stability, nuclear processing, and immune
response.5–8 Therefore transcriptome-wide annotation of m6A sites
will be helpful to understand its biological functions.
In the past few years, high-throughput sequencing techniques such as
MeRIPSeq9 and m6A-seq10 have identified m6A peaks in Saccharo-
myces cerevisiae, Mus musculus, and Homo sapiens. At the sameMolecular Thera
This is an open access article under ttime, the miCLIP technique11 was proposed to provide the recogni-
tion method of m6A sites in the human transcriptome. However, in
consideration of the biological inherent reliance of the techniques,12
they are still neither budget nor time efficient in performing tran-
scriptome-wide analysis.
Although lab-based technologies have been widely applied to iden-
tify m6A, some cost-effective computational methods are developed
in assisting the process as well. To identify methylated m6A sites,
building a high-resolution database is of paramount importance
in predicting m6A sites. Using the high-resolution database of
Saccharomyces cerevisiae constructed by Schwartz et al.,13 Chen
et al.14–18 proposed a series of predictors such as “iRNA-Methyl,”
“M6ATH,” “MethyRNA,” “iRNA-3typeA” and “iRNA(m6A)-
PseDNC,” which formulated RNA sequences by using different
combinations of feature extractions and classifiers to make predic-
tions. Feng et al.19 used a method called “iRNA-PseColl,” which
incorporated collective features of the RNA sequence elements
into PseKNC to make predictions. Jaffrey et al.11 built a single-
nucleotide resolution map of m6A sites across Homo sapiens.
More recently, Chen et al.20 proposed a support-vector-machine-
based method to predict m6A sites in Arabidopsis thaliana. As
mentioned in some references, well-established ensemble classifiers
have been proven to outperform single classifiers.21–23 Based on this,
Wei et al.24 thus proposed an m6A predictor by constructing an
ensemble classifier based on the support vector machine (SVM) to
successfully improve the predictive performance. Wei et al.25,26
have also done a lot of research with the ensemble classifier, which
has great significance for reference in our study.
In this article, we propose a novel method for the identification of
m6A sites within RNA sequences. As for feature representation, we
use the frequent gapped k-mer pattern (FGKP) discovery algorithmpy: Nucleic Acids Vol. 18 December 2019 ª 2019 The Authors. 673
he CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1. Comparison of Different Feature Extractions
Feature SP (%) SN (%) ACC (%) MCC AUROC
Triplet 56.92 63.85 59.92 0.20 0.6669
Pse-SSC 78.77 64.66 72.52 0.44 0.7284
Frequent gapped k-mer 71.92 83.62 77.10 0.55 0.8307
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Figure 2. ROCCurves of Frequent Gapped K-mer, Pse-SSC, and Triplet and
Their AUROC Values
Molecular Therapy: Nucleic Acidsto mainly capture the properties in RNA sequences. In the predictive
model, we use the linear regression to discriminate the positive and
negative samples. Experimental results show that our model outper-
formed other existing methods in the literature under the 10-fold
cross-validation test.
RESULTS
Several diseases have their underlying causes in RNA,27,28 including
cancers.29–31 In our study, we combined the advantage of effective
extraction of frequent gapped k-mer (FGK) and the strong ability
of classification of the linear predictive model to create a powerful
predictive tool in order to discriminate the positive and negative
samples of m6A. The learning machine that we used was logistic
regression (LR). We have experimented with our predictor in the
Saccharomyces cerevisiae genome using 10-fold cross-validation. It
turns out that our model is superior to M6A-HPCS, the recent clas-
sifier in this area, and also has a better performance than other feature
extractions and different parameters within our model. We anticipate
that it will shed some light on genome analysis in future practice.
Four Evaluation Metrics
In general, the following four metrics are used to measure the quality
of a predictor:32 sensitivity (SN), specificity (SP), accuracy (ACC), and
Matthews correlation coefficient (MCC). These metrics were first
introduced by Chou33 and then they were widely applied to a wide
range of biological areas (see Liu et al.,34–37 Ehsan et al.,38 Feng
et al.,19 Song et al.,39 Lin et al.,40 and Xu et al.40,41). Their definitions
are as follows:Figure 1. Performance of Different Feature Extractions Using 10-Fold
Cross-validation
Here, we compare the effect of our feature extraction (FGK) with Pse-SSC and
Triplet methods.
674 Molecular Therapy: Nucleic Acids Vol. 18 December 2019SP =
TN
TN + FP
 100% (Equation 1)
SN =
TP
TP + FN
 100% (Equation 2)
ACC =
TP +TN
TP + FN +TN + FP
 100% (Equation 3)
and
MCC =
TP  TN  FP  FNffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiðTP + FNÞðTN + FPÞðTP + FPÞðTN + FNÞp
(Equation 4)
where TP, TN, FP, and FN are true positive, true negative, false pos-
itive, and false negative, respectively. In this research, TP represents
the true m6A site predicted correctly, TN represents the non-m6A
site predicted incorrectly, FP represents the non-m6A site predicted
incorrectly as the true m6A site, and FN represents the non-m6A
site predicted correctly as the non-m6A site. The values of SN, SP,
ACC, are between 0 and 1. The closer to 1 they get, the more accuracy
our model achieves; the value ofMCC is between1 and 1. The larger
the value thatMCC gets, the better performance our prediction model
obtains.
Cross-Validation
Normally, three types of validation are used to derive themetric values:
independent test sets, subsampling (or K-fold cross-validation), and
Table 2. Performance Comparison of Different Classifiers
Classifier SP (%) SN (%) ACC (%) MCC
SVM 80 46.83 48.09 0.10
RF 75.51 72.56 73.66 0.47
LR 71.92 83.62 77.10 0.55
Table 3. Performance Comparison of Different Parameters in Our Model
Classifier SP (%) SN (%) ACC (%) MCC
LR (k = 5, g = 0.05) 73.53 73.81 73.66 0.47
LR( k = 4, g = 0.025) 71.92 83.62 77.10 0.55
www.moleculartherapy.orgthe jackknife test (or LOOCV). Although the jackknife test can fully
train the data we already have to acquire a more accurate classifier,
and it has definite sampling and error estimation based on the specific
dataset, the jackknife test is not a time-efficientmethod comparedwith
the other two types of validation. In this article, we adopted the 10-fold
cross-validation method used by many researchers42–44 in this area.ROC Curve
ROC curve (also called the sensitivity curve) is the abbreviation for
receiver operating characteristic curve. Every point on the curve re-
flects the same sensitivity. They react to the same signal simulation
in the different judgment standards. Therefore, the ROC curve can
be generally treated as the overall performance in the binary classifi-
cation problems. The ROC curve is normally plotted with the x-axis
true-positive rate (TPR) and the y-axis false-positive rate (FPR) in the
different thresholds of the classification. We can understand the TPR
as the sensitivity as described earlier, and the FPR can be computed as
1  specificity. The area under the ROC curve (AUROC) can also be
calculated. The AUROC is the indicator of the performance of a pre-
dictor. The AUROC ranges from 0.5 to 1. The closer the AUROC
score of a predictor to 1, the better and more robust the predictor
we can reckon, and we can deem the AUROC score of 0.5 of a predic-
tor as a random predictor.DISCUSSION
Comparison among Different Feature Extractions
To justify our feature extraction technique, we make comparisons
with two of the most commonly used feature representation tech-
niques, Triplet and Pse-SSC, and this shows that the FGK methodFigure 3. Comparison of Performances among the LR Classifier and Other
Popular Classifiers (SVM and RF) with the Same Learning Feature
Representations on the S. cerevisiae Datasetgets the much better performance than the other two feature repre-
sentations. We show the result in Table 1, and from Figure 1, we
can see the graphical comparisons from four different evaluationmet-
rics. The FGK leads Pse-SSC by 4% and Triplet by 17% for the ACC,
and for the MCC metric, FGK outnumbers its counterparts by over
10%. From Figure 2, we can see the effects of three different feature
extractions from their ROC curves. The larger areas under the curve
we get, the better performance the method achieves. Also, we can also
see from Table 1 that our feature representation is 63.2% and 16.4%
higher than features Pse-SSC and Triplet, respectively.
Comparison with Other Classifiers
In Table 2, we compare LR with SVM and random forest (RF). The
reason for choosing SVM and RF for comparison is because
SVM20,21,45,46 and RF5,47–50 are two of the most widely used classi-
fiers in bioinformatics. Although the SP of the proposed method is
lower than those of SVM and RF, its SN, ACC, and MCC are higher
than those of SVM and RF, indicating that the performance of the
LR-based model can effectively discriminate the m6A sites in
Saccharomyces cerevisiae. We can see the overall performance of
three classifiers in Figure 3. In this figure, we can see that, although
the SP of LR performs poorly compared to that of the other two clas-
sifiers, the other three metrics are much better than the rest for the
two predictors. The ACC of LR is far better than that of SVM,
topping by almost 30% and slightly exceeding by 3.5% the ACC
of RF.
Comparison with Different Parameters
In Table 3, we compared the model prediction performance of linear
regression using different parameters and found that, with parame-
ters k = 4 and g = 0.025, we get the most desirable result. The classifier
with parameters k = 5 and g = 0.05 is almost 25% higher than its
counterpart in ACC.
Comparison with Existing Predictors
To evaluate the performance of our proposed predictor, we compared
our predictor with two existing predictors, iRNA-Methyl14 andM6A-
HPCS.51 The reason to choose these two predictors for comparison is
that they have been reported to achieve outstanding performance inTable 4. Comparison of M6APred-FG with Other Well-Known Classifiers
Prediction Method SP (%) SN (%) ACC (%) MCC
iRNA-Methyl 60.63 70.59 65.59 0.29
M6A-HPCS 62.89 71.77 67.33 0.35
iRNA-Freq 71.92 83.62 77.10 0.55
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Figure 4. Flowchart of the Proposed Predictor
Stage 1 shows the procedure of dataset preparation. We chose a benchmark database and used updated literature to obtain candidate peptides. Since the candidate
peptides have imbalanced positive and negative samples, we needed to balance the samples (or reduce redundancy) to get the primary dataset. Then, we divided the dataset
into the test dataset and the train dataset. Stage 2 shows the feature encoding or feature extraction. In our sample sequences, there is information hidden. We needed to find
a way to extract their features to best represent the original samples and digitalize them. Stage 3 shows how we used the train dataset and chose the appropriate model to
gain a prediction model and evaluate it. Stage 4 shows how we tested and validated our predictive model. In our article, we combined stages 3 and 4 together using 10-fold
cross-validation to evaluate our model.
Molecular Therapy: Nucleic Acidsm6A site identification. For fairness of comparison, all compared pre-
dictors are trained and validated on the same benchmark dataset. The
results are summarized in Table 4. It can be observed that, among the
compared predictors, the proposed model obtains the best perfor-
mance in terms ofACC andMCC, with 77.10% and 55%, respectively.
Compared with the best of the existing predictors, M6A-HPCS, our
classifier performance is about 10% higher for ACC and 20% higher
for MCC.MATERIALS AND METHODS
Framework of the Proposed Predictor
Figure 4 shows the flowchart of the proposed predictor. The first stage
is to collect data from verified databases and relevant literature.14,15,52
In this research, we use the organized dataset from Chen et al.’s14
work. The second stage is feature encoding. This stage includes
feature representation and feature optimization. Feature representa-
tion means extracting characteristics of RNA sequences using various
feature descriptors, including composition features like Dinucleotide-
based auto covariance (DAC), physicochemical features like PC-676 Molecular Therapy: Nucleic Acids Vol. 18 December 2019PseDNC-General, and our newly found FGKP. The final stage is to
train the machine learning model (i.e., SVM, RF, and linear regres-
sion) using the feature extraction from the last stage. The predictive
model constructed is based on the feature extraction mentioned
earlier and validated through validation methods. In this study, we
used the 10-fold cross-validation test.Datasets
m6A sites have been widely identified in Saccharomyces cerevisiae,13
Homo sapiens,10,11 Mus musculus,10 and Arabidopsis thaliana.53 In
this work, we used the dataset from Saccharomyces cerevisiae. In
the Saccharomyces cerevisiae genome, m6A sites have the same motif,
GAC, and they are more easily methylated.13 Since RNA sequences in
Saccharomyces cerevisiae have different lengths, we used the orga-
nized dataset from Chen et al.’s14 work. There are 1,307 positive sam-
ples and 1,307 negative samples, where the negative samples were
randomly collected from 33,280 sequences with non-m6A sites. All
sequences in the dataset are 51 nt long (25 nt on each side of the
m6A/non-m6A sites), with the sequence similarity less than 85%.
Seq 1 ...GCUGAAGCGCCUCUCGGACUGCAA...
Seq 2 ...GAACAAGCCAAUGACUAAGCG...
Seq 3 ...AAGCGCAGCGAGUCGACUGCAUG...
Seq 4 ...GCAUCUAAGCCGACUGAUUGACUCAU...
            ...
Seq1
Seq2
Seq3
Seq4
...
...
...
...
AAGC
...
...
1
1
1
1
1
1
1
0
... GACU ...
... ...
...
...
...
......
...
...
...
.........
Figure 5. The Transformation from the Original Samples to 0–1 Sequences
www.moleculartherapy.orgRepresentation of RNA Sample
The RNA samples in our dataset can be generally expressed as the
following pattern:
R = M1M2M3/M51 (Equation 5)
where
Mi˛fAðadenineÞ;Cðcyto sin eÞ;GðguanineÞ;UðuracilÞgi =
1; 2; 3;/; 51:
The first thing we would need to do is to transform the RNA
sequence in Equation 5 to a vector. However, a vector might lose
its sequential information and pattern. In order to solve the prob-
lem, we introduce the FGKP discovery algorithm that we recently
found. In this method, we can separate our algorithm into four steps
and elaborate each step accordingly:
(1) Search all the FGK sub-sequences from each sequence in the da-
taset.
We find all FGK sub-sequences from each sequence in the dataset and
calculate the frequency of gapped k-mer sub-sequences, and we can
set the frequency threshold here. Here, the parameter k means the
matching length of the sub-sequences, and we denote the frequency
threshold as g.
(2) Build a set for the frequent sub-sequences.FGK are subjects and whose lengths over a threshold is an attribute
clause which modifies the subjects. We can map each FGK sub-
sequence into a column of the table as shown in Figure 5.
(3) Utilize the frequent k-mer sub-sequence set as features to
generate vectors.
First of all, we define the following functions:
c

Si; FkMj

=

1; if FkMj exactly matches Si
0; Otherwise
(Equation 6)
fðSiÞ =
0
B@
cðSi; FkM1Þ
cðSi; FkM2Þ
.
cðSi; FkMnÞ
1
CA: (Equation 7)
Here, Si denotes the sequence that is predicted, and FkMj denotes the
j-element of the frequent k-mer sub-sequence set. As you can see from
the function in Equation 6, we define a function c, which compares
the predicted sequence Si and the j-element of the frequent k-mer
sequence set, and we discriminate the perfect matching between Si
and FkMj using 1 and 0 otherwise. After this procedure, we map
the sequence Si using the function f to a 0–1 vector as shown in
the function in Equation 7.Linear Predictive Model
Although a huge amount of literature is related to classification
methods such as SVM21,52,54–62 and RF,5,47–50 as we can see from
the feature representation algorithm of RNA sample, a series of sparse
data is produced. Therefore, the need to deal with a large amount of
sparse data is imperative. The linear predictive model is a linear clas-
sifier for processing a large amount of sparse data with a large number
of examples and features. It is a general term for supervised models,
including LR, SVM, and support vector regression (SVR). In this
study, we used the packages LIBSVM63 and LIBLINEAR.64 They sup-
port the multiple types of linear classifiers that we mentioned earlier.
In this study, we used LR and achieved a good result. LR uses the
optimal decision boundary to construct regression formula and fitted
parameter sets. The main idea is as follows:
1. Construct the prediction function hq, where q represents the
parameter sets of eigenvalue X.
As far as we know, hqcould have a linear relationship or non-linear
relationship with X, as we can see from Figure 6. Normally, we can
represent the linear relationship between hqand X using the formula
hqðxÞ = gðq0 + q1x1 + q2x2Þ (Equation 8)
and the non-linear relationship using the formula
hqðxÞ = g

q0 + q1x1 + q2x2 + q3x
2
1 + q4x
2
2

: (Equation 9)Molecular Therapy: Nucleic Acids Vol. 18 December 2019 677
y=0
y=1
y=1
y=1
y=1
1x
2x
Linear Relationship Non-linear Relationship Figure 6. The Linear and Non-linear Relationships
between hqand X
For details, see the Linear Predictive Model section in
Materials and Methods.
Molecular Therapy: Nucleic AcidsIn linear programming, the idea of cost function is to minimize the
difference of predictive result hqand actual y; i.e.,
JðqÞ = 1
m
Xm
i= 1
1
2

hq

xðiÞ
 yðiÞ2: (Equation 10)
Then in LR, we can represent JðqÞ as:
JðqÞ = 1
m
Xm
i= 1
Cost

hq

xðiÞ

; yðiÞ

: (Equation 11)
2. Use gradient descent to calculate the maximum of JðqÞ.
We can achieve the maximum of JðqÞ through fitting parameters us-
ing the gradient of the function. For simplicity, we can consider the
following cost function
JðqÞ = 1
m
Xm
i= 1
Cost

hq

xðiÞ

; yðiÞ

(Equation 12)
CostðhqðxÞ; yÞ =
 logðhqðxÞÞ if y = 1
logð1 hqðxÞÞ if y = 0 (Equation 13)
and we can renew the parameter qj: = qj + aðvJðqÞ =vqjÞ; that is,
qj : = qj  a
Xm
i= 1

hq

xðiÞ
 yðiÞxðiÞj : (Equation 14)
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